Aspira Pathlab executes agreement with Om Diagnostics Lab

03 Sep 2018 Evaluate

Aspira Pathlab & Diagnostics has executed a business transfer agreement with Om Diagnostics Lab and ultimate promoters of Om Diagnostics inter-alia for acquisition of business of Om Diagnostics. The acquisition is expected to result in expansion of business of the company. The cost of acquisition is Rs 2 crore.

Aspira Pathlab & Diagnostics is an inventive venture in quality healthcare and the pioneer in comprehensive reliance on technological automation. The company offers wide ranging diagnostic services which assist in mapping the entire journey of a patient’s prognosis, remission and eventual recuperation.


Aspira Pathlab&Diagn Share Price

67.68 0.93 (1.39%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7189.25
Max Healthcare Inst 1097.95
Narayana Hrudayalay 1916.45
Aster DM Healthcare 635.10
Global Health 1163.75
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×